TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
-5.96%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$256M
AUM Growth
+$256M
(+2.6%)
Cap. Flow
+$29.5M
Cap. Flow
% of AUM
11.53%
Top 10 Holdings %
Top 10 Hldgs %
54.27%
Holding
60
New
20
Increased
9
Reduced
8
Closed
21
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$20.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$15M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$13.9M |
| 4 |
Celldex Therapeutics
CLDX
|
$13.1M |
| 5 |
Protagonist Therapeutics
PTGX
|
$10.8M |
Top Sells
| 1 |
AbbVie
ABBV
|
$24.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$15M |
| 3 |
Eli Lilly
LLY
|
$10.6M |
| 4 |
United Therapeutics
UTHR
|
$9.92M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.27M |
Sector Composition
| 1 | Healthcare | 93.68% |
| 2 | Consumer Staples | 3.25% |
| 3 | Financials | 0.07% |
| 4 | Real Estate | 0.04% |
| 5 | Technology | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
AbbVie
ABBV
$374B
| – | – |
-179,950
| Closed | -$24.4M |
|
52
Aclaris Therapeutics
ACRS
$223M
| – | – |
-55,433
| Closed | -$806K |
|
53
American Well
AMWL
$112M
| – | – |
-11,244
| Closed | -$1.36M |
|
|
54
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-318,269
| Closed | -$15M |
|
55
Cytokinetics
CYTK
$5.98B
| – | – |
-33,379
| Closed | -$1.52M |
|
56
DURECT Corp
DRRX
$60.2M
| – | – |
-2,639
| Closed | -$26K |
|
57
Legend Biotech
LEGN
$6.64B
| – | – |
-89,840
| Closed | -$4.19M |
|
|
SNCE
58
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| – | – |
-13,558
| Closed | -$3.38M |
|
|
SGEN
59
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-59,940
| Closed | -$9.27M |
|
|
CANO
60
DELISTED
Cano Health, Inc.
CANO
| – | – |
-1,415
| Closed | -$1.26M |
|